Performance Improvement in Passive Backscatter Based RFID System with Low DCR Modulations

This paper presents application of the low Duty Cycle Ratio (DCR) modulations: isochronous Digital Pulse Position Modulation (DPPM) and anisochronous Digital Pulse Interval Modulation (DPIM) in backscatter based passive RFID communication system. The proposed modulations are compared to commonly used Amplitude Shift Keying (ASK) modulation. Low DCR modulations are customized for data transmission through inductively coupled link between reader and the tag operating at frequency of 13.56 MHz. The RFID system is mathematically formulated and the performances of the tag are evaluated for each modulation. Observed parameters are modulation depth of backscattered signal, voltage-current characteristics of tag rectifier circuit and ripple of rectifier output voltage. The application of proposed low DCR modulation techniques improves the performance of the RFID system by up to 250%

Practical reasoning in political discourse: The UK government's response to the economic crisis in the 2008 Pre-Budget Report

This article focuses on practical reasoning in political discourse and argues for a better integration of argumentation theory with critical discourse analysis (CDA). Political discourse and its specific genres (for example, deliberation) primarily involve forms of practical reasoning, typically oriented towards finding solutions to problems and deciding on future courses of action. Practical reasoning is a form of inference from cognitive and motivational premises: from what we believe (about the situation or about means—end relations) and what we want or desire (our goals and values), leading to a normative judgement (and often a decision) concerning action. We offer an analysis of the main argument in the UK government’s 2008 Pre-Budget Report (HM Treasury, 2008) and suggest how a critical evaluation of the argument from the perspective of a normative theory of argumentation (particularly the informal logic developed by Douglas Walton) can provide the basis for an evaluation in terms of characteristic CDA concerns. We are advancing this analysis as a contribution to CDA, aimed at increasing the rigour and systematicity of its analyses of political discourse, and as a contribution to the normative concerns of critical social science

Functional responses in a lizard along a 3.5-km altitudinal gradient

Aim: Physiological and metabolic performance are key mediators of the functional response of species to environmental change. Few environments offer such a multifaceted array of stressors as high-altitude habitats, which differ markedly in temperature, water availability, UV radiation and oxygen pressure compared to low-altitude habitats. Species that inhabit large altitudinal gradients are thus excellent models to study how organisms respond to environmental variation. Location: Tenerife island, Canary Islands archipelago (Spain). Taxon: Tenerife lizard (Gallotia galloti, Lacertidae). Methods: We integrated data on age structure, thermal and hydric regulatory behaviour and four metabolic and stress-related biomarkers for an insular lizard that inhabits an extreme altitudinal range (sea level to 3700 m a.s.l.), to understand how an ectotherms' age, ecophysiology and metabolism can be affected by extreme environmental variation. Results: We found marked differences in metabolic stress markers associated with altitude (particularly in the abundance of carbonyl metabolites and relative telomere length), but without a linear pattern along the altitudinal cline. Contrary to expectations, longer telomeres and lower carbonyl content were detected at the highest altitude, suggesting reduced stress in these populations. Evaporative water loss differed between populations but did not follow a linear altitudinal gradient. Lizard age structure or thermal physiological performance did not markedly change across different altitudes. Mixed signals in life-history and thermal ecology across populations and altitude suggest complex responses to variable conditions across altitude in this species. Main Conclusions: Our integrative study of multiple functional traits demonstrated that adaptation to highly divergent environmental conditions in this lizard is potentially linked to an interplay between plasticity and local adaptation variably associated with different functional traits

Wrinkling of foils

Aluminum and copper metal webs less than 150 microns (6-mils) are considered foils. Demand for aluminum and copper foils are growing, driven by growing markets for flexible electronics, flat panel displays, lithium batteries, and solar products. In many of these products, thinner foils have cost or weight advantages, but as with nearly any web, thinner means an increased sensitivity to wrinkling in web handling processes.Nearly all of published web handling research and development work have been based on polymer films and paper webs. Since the web wrinkling theories are based on first principles, they should apply to the foil webs. However, applying models confirmed with paper or foil on narrow widths (less than 0.3m or 12-in wide) to the uncharted territories of foils with 20x elastic modulus and 4x width increases will likely lead to interesting discoveries.This paper will present a comparison of empirical wrinkling results from trials of handling thin and wide aluminum and copper foils (less 25 micron thick by greater than 0.6m wide (less than 0.001-in thick by 24-in. wide). The experimental results will be compared to wrinkling theory, with conclusion about how wrinkling in foils differs from film and paper webs

Quality of care indicators for head and neck cancers : the experience of the European project RARECAREnet

Background: Monitoring and improving quality of cancer care has become pivotal today. This is especially relevant for head and neck cancers since the disease is complex, it needs multi therapy, patients tend to be older, they tend to have comorbidities and limited social support. However, information on quality of care for head and neck cancers is scarce. In the context of the project "Information Network on Rare Cancers" we aimed to identify indicators of quality of care specific for the head and neck cancers management and to measure the quality of care for head and neck cancers in different EU Member States. Methods: We defined indicators of quality of care for head and neck cancers based on a multidisciplinary and expert-based consensus process at a European level. To test the proposed indicators, we performed an observational population-based retrospective study in four countries (Ireland, Italy, Netherlands, and Slovenia) in the years 2009-2011. Results: The main quality indicators identified are: availability of formalized multidisciplinary team, participation in clinical and translational research; timeliness of care, high quality of surgery and radiotherapy, and of pathological reporting. For head and neck cancers, the quality of care did not reach the optimal standards in most of the countries analyzed. A high proportion of patients was diagnosed at an advanced disease stage, showed delays in starting treatment (especially for radiotherapy), and there was only a very limited use of multi therapy. Conclusions: According to the achieved consensus, indicators of quality of care for head and neck cancers have to cover the patient journey (i.e., diagnosis and treatment). Our results, showed suboptimal quality of care across countries and call for solutions for ensuring good quality of care for head and neck cancer patients in all EU countries. One possible option might be to refer head and neck cancer patients to specialized centers or to networks including specialized centers

A Study of the Day - Night Effect for the Super - Kamiokande Detector: I. Time Averaged Solar Neutrino Survival Probability

This is the first of two articles aimed at providing comprehensive predictions for the day-night (D-N) effect for the Super-Kamiokande detector in the case of the MSW \nu_e \to \numt transition solution of the solar neutrino problem. The one-year averaged probability of survival of the solar \nue crossing the Earth mantle, the core, the inner 2/3 of the core, and the (core + mantle) is calculated with high precision (better than 1%) using the elliptical orbit approximation (EOA) to describe the Earth motion around the Sun. Results for the survival probability in the indicated cases are obtained for a large set of values of the MSW transition parameters $\Delta m^2$ and $sin^22\theta_{V}$ from the ``conservative'' regions of the MSW solution, derived by taking into account possible relatively large uncertainties in the values of the $^{8}$B and $^{7}$Be neutrino fluxes. Our results show that the one-year averaged D-N asymmetry in the $\nu_e$ survival probability for neutrinos crossing the Earth core can be, in the case of $sin^22 \theta_{V} \leq 0.13$, larger than the asymmetry in the probability for (only mantle crossing + core crossing) neutrinos by a factor of up to six. The enhancement is larger in the case of neutrinos crossing the inner 2/3 of the core. This indicates that the Super-Kamiokande experiment might be able to test the $sin^22\theta_{V} \leq 0.01$ region of the MSW solution of the solar neutrino problem by performing selective D-N asymmetry measurements.Comment: LaTeX2e - 18 Text Pages + 21 figures = 39 Pages. - Figures in PS + text file sk1b14.tex requires two auxiliary files (included

Spinal intradural extraosseous Ewing's sarcoma

Extraosseous Ewing's sarcoma (EES) involving the central nervous system is rare, but can be diagnosed and distinguished from other primitive neuroectodermal tumors (PNET) by identification of the chromosomal translocation (11;22)(q24;q12). We report EES arising from the spinal intradural extramedullary space, based on imaging, histopathological, and molecular data in two men, ages 50 and 60 years old and a review of the literature using PubMed (1970–2009). Reverse transcriptase polymerase chain reaction (RT-PCR) identified the fusion product FL1-EWS. Multimodal therapy, including radiation and alternating chemotherapy including vincristine, cyclophosphamide, doxorubicin and ifosfamide and etoposide led to local tumor control and an initial, favorable therapeutic response. No systemic involvement was seen from the time of diagnosis to the time of last follow-up (26 months) or death (4 years). This report confirms that EES is not confined to the earliest decades of life, and like its rare occurrence as an extra-axial meningeal based mass intracranially, can occasionally present as an intradural mass in the spinal canal without evidence of systemic tumor. Gross total resection followed by multimodal therapy may provide for extended progression free and overall survival

Changing Natural History of HER2–Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies

Patients with breast cancer brain metastases historically have a poor prognosis. In this single-institution cohort study of patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases, we found no improvement in survival after brain recurrence over time despite wide adoption of HER2–targeted therapies. This highlights the importance of continued development of novel brain penetrant therapies for patients with HER2–positive metastatic disease to extend survival and improve quality of life. Background: Given the wide adoption of human epidermal growth factor receptor 2 (HER2)-targeted therapies for advanced HER2–positive breast cancer, we studied the natural history of patients with HER2–positive breast cancer brain metastases (BCBM) over time. Patients and Methods: Patients with HER2–positive BCBM identified from a prospectively maintained database at the University of North Carolina were divided into 3 cohorts by year of BCBM diagnosis. Cohorts were selected by year of HER2–targeted therapy US Food and Drug Administration approval. Overall survival (OS), time to first metastasis, time to BCBM, and BCBM survival were estimated by the Kaplan-Meier method. Associations between OS after BCBM and clinical variables were assessed by Cox proportional hazards regression models. Results: One hundred twenty-three patients were identified. Median age was 51 years, and 58% were white and 31% African American. OS from initial breast cancer diagnosis improved over time: 3.6 years (95% confidence interval [CI], 2.8-6.1) in the 1998-2007 cohort, 6.6 years (95% CI, 4.5-8.6) in the 2008-2012 cohort, and 7.6 years (95% CI, 4.4-9.6) in the 2013-2015 cohort (P =.05). While time from initial diagnosis to first metastasis did not differ (P =.12), time to BCBM increased over time (2.6 years [95% CI, 1.3-3.5] for 1998-2007; 2.6 years [95% CI, 2.1-4.3] for 2008-2012, and 3.3 years [95% CI, 2.2-6] for 2013-2015; P =.05). Although OS from BCBM did not significantly differ by cohort, patients who received HER2–targeted therapy after BCBM had a prolonged OS (2.1 years [95% CI, 1.6-2.6] vs. 0.65 years [95% CI, 0.4-1.3]; P =.001). Conclusion: OS from initial breast cancer diagnosis significantly improved over time for patients with HER2–positive breast cancer who develop BCBM, now exceeding 7 years; survival from BCBM diagnosis may now exceed 2 years

LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases

Purpose: HER2 + breast cancer (BC) is an aggressive subtype with high rates of brain metastases (BCBM). Two-thirds of HER2 + BCBM demonstrate activation of the PI3K/mTOR pathway driving resistance to anti-HER2 therapy. This phase II study evaluated everolimus (E), a brain-permeable mTOR inhibitor, trastuzumab (T), and vinorelbine (V) in patients with HER2 + BCBM. Patients and methods: Eligible patients had progressive HER2 + BCBM. The primary endpoint was intracranial response rate (RR); secondary objectives were CNS clinical benefit rate (CBR), extracranial RR, time to progression (TTP), overall survival (OS), and targeted sequencing of tumors from enrolled patients. A two-stage design distinguished intracranial RR of 5% versus 20%. Results: 32 patients were evaluable for toxicity, 26 for efficacy. Intracranial RR was 4% (1 PR). CNS CBR at 6 mos was 27%; at 3 mos 65%. Median intracranial TTP was 3.9 mos (95% CI 2.2–5). OS was 12.2 mos (95% CI 0.6–20.2). Grade 3–4 toxicities included neutropenia (41%), anemia (16%), and stomatitis (16%). Mutations in TP53 and PIK3CA were common in BCBM. Mutations in the PI3K/mTOR pathway were not associated with response. ERBB2 amplification was higher in BCBM compared to primary BC; ERBB2 amplification in the primary BC trended toward worse OS. Conclusion: While intracranial RR to ETV was low in HER2 + BCBM patients, one-third achieved CNS CBR; TTP/OS was similar to historical control. No new toxicity signals were observed. Further analysis of the genomic underpinnings of BCBM to identify tractable prognostic and/or predictive biomarkers is warranted. Clinical Trial: (NCT01305941)